首页|丹参注射液联合乙酰半胱氨酸雾化吸入治疗慢性阻塞性肺疾病急性加重期患者的效果

丹参注射液联合乙酰半胱氨酸雾化吸入治疗慢性阻塞性肺疾病急性加重期患者的效果

扫码查看
目的:观察丹参注射液联合乙酰半胱氨酸雾化吸入治疗慢性阻塞性肺疾病急性加重期(AECOPD)患者的效果.方法:选取 2022 年 9 月至 2023 年 12 月该院收治的 78 例AECOPD患者进行前瞻性研究,按照随机数字表法将其分为观察组和对照组各 39 例.两组均予以常规治疗,在此基础上,对照组予以乙酰半胱氨酸雾化吸入治疗,观察组在对照组基础上联合丹参注射液治疗,两组均持续治疗14 d.比较两组临床疗效,治疗前后炎性指标[C反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]水平、T细胞亚群指标(CD3+、CD4+、CD8+、CD4+/CD8+)水平、圣乔治呼吸问卷(SGRQ)评分,以及不良反应发生率.结果:观察组治疗总有效率为 94.87%(37/39),高于对照组的 76.92%(30/38),差异有统计学意义(P<0.05);治疗后,观察组CRP、IL-6、TNF-α水平均低于对照组,差异有统计学意义(P<0.05);治疗后,观察组CD3+、CD4+、CD4+/CD8+水平高于对照组,CD8+水平低于对照组,差异均有统计学意义(P<0.05);治疗 7、14 d后,观察组SGRQ评分均低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:丹参注射液联合乙酰半胱氨酸雾化吸入治疗AECOPD患者可提高治疗总有效率,降低炎性指标水平和SGRQ评分,改善T细胞亚群指标水平,效果优于单纯乙酰半胱氨酸雾化吸入治疗.
Effects of Danshen injection combined with Acetylcysteine aerosol inhalation in treatment of patients with acute exacerbation of chronic obstructive pulmonary disease
Objective:To observe effects of Danshen injection combined with Acetylcysteine aerosol inhalation in treatment of patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:A prospective study was conducted on 78 patients with AECOPD admitted to the hospital from September 2022 to December 2023.According to the random number table method,they were divided into observation group and control group,39 cases in each group.Both groups were given routine treatment.On this basis,the control group was treated with Acetylcysteine aerosol inhalation,while the observation group was treated with Danshen injection on the basis of that of the control group.Both groups were treated for 14 d.The clinical efficacy,the inflammatory indexes[C-reactive protein(CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)]levels,the T cell subsets(CD3+,CD4+,CD8+,CD4+/CD8+)levels and the St.George's respiratory questionnaire(SGRQ)scores before and after treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 94.87%(37/39),which was higher than 76.92%(30/38)of the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of CRP,IL-6 and TNF-α in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of CD3+,CD4+and CD4+/CD8+in the observation group were higher than those in the control group,the level of CD8+was lower than that in the control group,and the differences were statistically significant(P<0.05).After 7 and 14 days of treatment,the SGRQ scores of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Danshen injection combined with Acetylcysteine aerosol inhalation in the treatment of the AECOPD patients can improve the total effective rate of treatment,reduce the levels of inflammatory indexes and the SGRQ scores,and improve the levels of T cell subsets.Moreover,it is superior to single Acetylcysteine aerosol inhalation therapy.

Acute exacerbation of chronic obstructive pulmonary diseaseAcetylcysteineDanshen injectionT cell subsetAdverse reaction

赵福军、李凯峰、张永良

展开 >

南京银城康复医院普通内科,江苏 南京 210000

慢性阻塞性肺疾病急性加重期 乙酰半胱氨酸 丹参注射液 T细胞亚群 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(10)
  • 12